Aurinia Pharmaceuticals Inc.
AUPH | NASDAQ
$16.70
+$0.09 (+0.54%)
Sep 22, 2026, 1:23 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 83.22M | 77.71M | 77.11M | 73.47M | 70.01M | 62.47M | 59.87M | 67.77M | 57.19M | 50.3M | 45.1M | 54.52M | 41.49M | 34.41M | 28.44M | 55.78M | 28.19M | 21.63M | 23.4M | 14.67M | 6.62M | 914K |
Cost of Revenue | 6.56M | 6.51M | 8.47M | 8.5M | 7.12M | 8.57M | 5.55M | 6.04M | 8.91M | 7.75M | 5.4M | 6.77M | 1.56M | 421K | 1.36M | 2.45M | 1.6M | 256K | 481K | 254K | 308K | 48K |
Gross Profit | 76.67M | 71.2M | 68.64M | 64.96M | 62.89M | 53.89M | 54.32M | 61.74M | 48.28M | 42.55M | 39.7M | 47.75M | 39.93M | 33.99M | 27.07M | 53.33M | 26.59M | 21.37M | 22.92M | 14.41M | 6.31M | 866K |
Operating Income | 46.34M | 41.42M | 33.24M | 29.75M | 20.08M | 21.85M | -1.67M | 11.75M | -1.51M | -10.7M | -29.67M | -16.26M | -16.17M | -29.58M | -28.1M | -9.5M | -35.99M | -37.88M | -32.71M | -50.35M | -47.13M | -50.54M |
Interest Income | 3.39M | 3.52M | 4.6M | 2.22M | 3.19M | 3.57M | 3.99M | 4.27M | 4.19M | 4.53M | 4.57M | 4.51M | 4.1M | 3.81M | 2.91M | 1.46M | 483K | 262K | 109K | 106K | 142K | 172K |
Pretax Income | 48.79M | 43.93M | 35.69M | 31.96M | 22.16M | 24.35M | 1.17M | 14.81M | 1.48M | -10.01M | -26.42M | -13.15M | -12.13M | -25.77M | -25.19M | -8.04M | -35.51M | -37.62M | -32.6M | -50.25M | -46.99M | -50.37M |
Net Income | 37.41M | 34.36M | 210.79M | 31.55M | 21.51M | 23.34M | 1.43M | 14.35M | 722K | -10.75M | -26.88M | -13.45M | -11.49M | -26.21M | -26.05M | -8.99M | -35.52M | -37.63M | -33.32M | -50.26M | -47.01M | -50.38M |
Selling & General & Admin | 23.51M | 22.03M | 29.26M | 26.18M | 26.02M | 20.34M | 45.26M | 42.37M | 44.93M | 47.7M | 50.07M | 47.76M | 43.64M | 50.12M | 47.47M | 52.17M | 51.53M | 45.2M | 44.24M | 44.65M | 44.32M | 39.81M |
Research & Development | 13.05M | 7.47M | 10.9M | 8.44M | 7.43M | 5.74M | 8.11M | 3.05M | 4.08M | 5.55M | 10.23M | 13.61M | 12.65M | 13.16M | 9.87M | 10.97M | 11.53M | 12.62M | 11.15M | 20.07M | 10.09M | 9.83M |
Other Expenses | -6.23M | 279K | -4.75M | 602K | 9.36M | 5.96M | 2.62M | 4.57M | 782K | n/a | 9.07M | 2.65M | -190K | 290K | -2.17M | -311K | -476K | 1.43M | 237K | 55K | -967K | 1.77M |
Operating Expenses | 30.32M | 29.78M | 35.4M | 35.22M | 42.81M | 32.04M | 55.98M | 49.99M | 49.8M | 53.25M | 69.37M | 64.01M | 56.1M | 63.57M | 55.17M | 62.83M | 62.58M | 59.25M | 55.63M | 64.77M | 53.45M | 51.41M |
Interest Expense | 948K | 1.01M | 6.51M | n/a | 1.12M | 1.07M | 1.15M | 1.21M | 1.2M | 1.28M | 1.31M | 1.4M | 65K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | 327K | 785K | 605K | 848K | 970K | 14.09M | 4.51M | 4.23M | 3.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 36.88M | 36.28M | 43.88M | 43.72M | 49.93M | 40.62M | 61.54M | 56.02M | 58.71M | 61M | 74.77M | 70.78M | 57.66M | 63.99M | 56.54M | 65.28M | 64.18M | 59.51M | 56.11M | 65.02M | 53.75M | 51.46M |
Income Tax Expense | 11.37M | 9.57M | -175.1M | 411K | 643K | 1.01M | -256K | 457K | 756K | 739K | 459K | 298K | -642K | 436K | 855K | 954K | 9K | 10K | 726K | 8K | 18K | 8K |
Shares Outstanding (Basic) | 130.08M | 132.38M | 134.37M | 137.18M | 138.92M | 138.92M | 142.18M | 143.05M | 143.33M | 144.01M | 143.62M | 142.85M | 142.78M | 142.64M | 142.27M | 141.86M | 141.73M | 141.68M | 132.05M | 128.44M | 128.22M | 127.4M |
Shares Outstanding (Diluted) | 133.53M | 137.64M | 138.7M | 136.01M | 143.2M | 138.92M | 147.68M | 145.65M | 144.11M | 144.01M | 143.62M | 142.85M | 142.78M | 142.64M | 142.27M | 141.86M | 141.73M | 141.68M | 132.05M | 128.44M | 128.22M | 127.4M |
EPS (Basic) | 0.29 | 0.26 | 1.58 | 0.24 | 0.16 | 0.16 | 0.01 | 0.10 | 0.01 | -0.07 | -0.19 | -0.09 | -0.08 | -0.18 | -0.18 | -0.06 | -0.25 | -0.27 | -0.25 | -0.39 | -0.37 | -0.40 |
EPS (Diluted) | 0.28 | 0.25 | 1.53 | 0.23 | 0.15 | 0.16 | 0.01 | 0.10 | 0.01 | -0.07 | -0.19 | -0.09 | -0.08 | -0.18 | -0.18 | -0.06 | -0.25 | -0.27 | -0.25 | -0.39 | -0.37 | -0.40 |
EBITDA | 54.57M | 49.75M | 47.07M | 36.83M | 28.14M | 30.27M | 7.18M | 20.91M | 7.52M | -3.88M | -20.16M | -6.29M | -11.35M | -25.05M | -24.97M | -7.23M | -34.52M | -36.78M | -31.91M | -49.48M | -46.14M | -50.13M |
EBIT | 49.73M | 44.94M | 42.2M | 31.96M | 23.27M | 25.42M | 2.32M | 16.02M | 2.68M | -8.73M | -25.11M | -11.75M | -12.07M | -25.77M | -25.19M | -8.04M | -35.51M | -37.62M | -32.6M | -50.25M | -46.99M | -50.54M |
Depreciation & Amortization | 4.83M | 4.82M | 4.86M | 4.87M | 4.86M | 4.86M | 4.86M | 4.89M | 4.84M | 4.85M | 4.95M | 5.46M | 719K | 717K | 219K | 809K | 991K | 838K | 688K | 766K | 848K | 416K |
Add to Watchlist
Select watchlists to add or remove AUPH